Reaction Details |
| Report a problem with these data |
Target | Oxytocin receptor |
---|
Ligand | BDBM50064735 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_149043 (CHEMBL762236) |
---|
Ki | 1±n/a nM |
---|
Citation | Bell, IM; Erb, JM; Freidinger, RM; Gallicchio, SN; Guare, JP; Guidotti, MT; Halpin, RA; Hobbs, DW; Homnick, CF; Kuo, MS; Lis, EV; Mathre, DJ; Michelson, SR; Pawluczyk, JM; Pettibone, DJ; Reiss, DR; Vickers, S; Williams, PD; Woyden, CJ Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines. J Med Chem41:2146-63 (1998) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Oxytocin receptor |
---|
Name: | Oxytocin receptor |
Synonyms: | OT-R | OXTR | OXYR_HUMAN | Oxytocin |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 42793.26 |
Organism: | Homo sapiens (Human) |
Description: | Oxytocin OXTR HEK293::B2R9L7 |
Residue: | 389 |
Sequence: | MEGALAANWSAEAANASAAPPGAEGNRTAGPPRRNEALARVEVAVLCLILLLALSGNACV
LLALRTTRQKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQV
VGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLATWLGCLVASAPQVHIFSLREV
ADGVFDCWAVFIQPWGPKAYITWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAA
AEAPEGAAAGDGGRVALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVW
DANAPKEASAFIIVMLLASLNSCCNPWIYMLFTGHLFHELVQRFLCCSASYLKGRRLGET
SASKKSNSSSFVLSHRSSSQRSCSQPSTA
|
|
|
BDBM50064735 |
---|
n/a |
---|
Name | BDBM50064735 |
Synonyms: | 1-(1-{4-[1-(2,4-Dimethyl-1-oxy-pyridin-3-ylmethyl)-piperidin-4-yloxy]-2-methoxy-benzoyl}-piperidin-4-yl)-1,4-dihydro-benzo[d][1,3]oxazin-2-one | CHEMBL302297 |
Type | Small organic molecule |
Emp. Form. | C34H40N4O6 |
Mol. Mass. | 600.7046 |
SMILES | COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2ccccc12 |
Structure |
|